On March 4, 2026, NPR reported on Colossal Biosciences’ effort to produce a cold-resistant elephant using woolly mammoth DNA and the genome of the Asian elephant, its closest living relative.[1] Colossal’s broader programme targets the woolly mammoth, Tasmanian tiger, and dodo; it previously announced genetically engineered dire wolves in 2025.[1] The mammoth strategy requires sequencing multiple ancient mammoths, assembling incomplete genomes, sequencing living elephant populations, and engineering selected mammoth traits rather than producing an exact genetic replica.[2][3]
The central technical lesson is that biological restoration depends on layered reference datasets, not merely frozen specimens. Ancient DNA is fragmented and incomplete, while living relatives supply viable cells, reproductive biology, and missing genomic context.[2][5] Colossal’s work includes a reference-quality Asian elephant genome produced with the Vertebrate Genomes Project in July 2022 and aims to compare broader elephant populations, potentially including 100 African and Asian elephants.[5][8] For the Lunar Ark, this supports preserving redundant genome assemblies, epigenetic data, viable cell lines, reproductive protocols, and the genomes of close living relatives. It also demonstrates that restoration outputs may be engineered functional analogues rather than authentic revivals, creating ecological, ethical, and containment risks.
The Ark team should establish a genomic-restoration standard requiring multiple independent genome sequences, authenticated provenance, reference genomes for living relatives, cryopreserved viable cells, and documented gene-function evidence. Monitor Colossal’s embryo, stem-cell, gestation, and population-genetics milestones; study its 11-step de-extinction pipeline; and integrate validated methods into a lunar biobank architecture with geographically and thermally redundant storage. Prioritise species whose restoration would provide critical ecosystem functions, while maintaining strict biosafety controls against uncontrolled release, genetic bottlenecks, and dependence on a single engineered lineage.[3]